VFI was invited to present at the GVIRF webinar “Vaccine Adjuvants for Global Health” organized on the 13th of September by NIH/NIAID, the Bill & Melinda Gates Foundation and the World Health Organization. As an introductory presentation of the webinar, our CEO Nicolas Collin shared his views on the Needs for an Adjuvant Global Market including the requirements to ensure global capacity, equitable access, and affordability of adjuvanted vaccines. During Session III, Céline Lemoine, Head of VFI Lausanne laboratories, provided an overview of our Adjuvant Portfolio to support the development of adjuvanted vaccines worldwide. These presentations highlighted VFI’s dedication to innovation and collaboration in the field of vaccine adjuvants in the fight against infectious diseases.
Feel free to download and share these presentations and do not hesitate to contact us for further information on VFI activities, projects and collaboration opportunities.
Presentation “Vaccine adjuvants: needs for a Global Market” (Nicolas Collin, page 1-15)
Presentation “VFI Adjuvant Portfolio” (Céline Lemoine, page 56-61)